학술논문
P3.02b-028 Characterizing Residual Erlotinib-Tolerant Population Using EGFR-Mutated NSCLC Primary Derived Xenografts: The Last Holdouts: Topic: EGFR Biomarkers
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology January 2017 12(1) Supplement:S1203-S1203
Subject
Language
ISSN
1556-0864